Appendix 4E - Preliminary Final Report
Filed with ASX · · 63 pages · English
2.4 No dividends have been paid or declared by the entity since the beginning of the current report period. 2.5 No dividends were paid for the previous corresponding period. 2.6 Please see section 14 for a brief explanation of the figures reported above. 3. Refer to the Attachment to Appendix 4E for the Statement of Comprehensive Income together with notes to the statement. 4. Refer to the Attachm
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- SCENESSE successful in Phase IIa vitiligo study
- Placement
- Observations from Clinuvels US vitiligo study published
- Five month study follow up - SCENESSE in vitiligo (CUV102)
- Clinuvel clears EMA manufacturing audit
Later from Clinuvel Pharmaceuticals
- Clinuvel books European Pre-Submission Meeting for SCENESSE
- Clinuvel completes first Phase II US study
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals